Agnafit Bidco, set up by private equity major Advent International and Aurora, the investment vehicle of Singapore’s GIC, has withdrawn an $8bn bid for Swedish drugmaker Orphan Biovitrum (SOBI).
The post Advent, GIC withdraw $8bn bid for Swedish drugmaker Orphan Biovitrum first appeared on AltAssets Private Equity News.
